COVID-19 vaccine development: What lessons can we learn from TB?
Abstract At the time of writing, the SARS-CoV-2 virus has infected more than 49 million people causing more than 1.2 million deaths worldwide since its emergence from Wuhan, China in December 2019. Vaccine development against SARS-CoV-2 has drawn the global attention in order to stop the spread of t...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2020-11-01
|
| coleção: | Annals of Clinical Microbiology and Antimicrobials |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s12941-020-00402-x |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|